Investigation of early prognostic factors in the development of early onset preeclampsia Nilay Karaca MD.

Slides:



Advertisements
Similar presentations
Hypertension in Pregnancy
Advertisements

The ACOG Task force on hypertension in pregnancy
HYPERTENSIVE DISORDERS OF PREGNANCY Dr. Dianne MP Graham, MD, CCFP Based on Guidelines From SOGC ALARM Course & WHO Guide on Managing Complications in.
Care of the pregnant woman Year 2 Lent term. The Case 38 year old booked at 12 weeks gestation in the antenatal clinic Expecting her third baby 1 st baby.
Angiogenic biomarkers for risk stratification in women with suspected preeclampsia Andreea Balan, Heather Young, Ph.D. 1, Linda Ojo, Jennifer Keller, M.D.
Sue Ann Smith, MD Neonatologist Doernbecher Neonatal Care Center
Cara Pessel, MD et al American Journal of Obstetrics and Gynecology 2013.
IN THE NAME OF GOD. CRITICALLY APPRAISED TOPIC If there is a Non-invasive prenatal testing for aneuploidies with low FPR at first trimester? If we can.
The Effects of Maternal Age on Childbirth Danielle Stevens, Advisor Jennifer Hancock Introduction There have been many studies that have analyzed the effects.
Eclampsia.
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
Hypertension in Pregnancy
MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.
Hypertension in Pregnancy Updates: ACOG Task Force 2013.
Diseases and Conditions of Pregnancy pre-eclampsia once called toxemia –a pregnancy disease in which symptoms are –hypertension –protein in the urine –Swelling.
PREECLAMPSIA IN PREGNANCY AND MIDWIFERY Kertu Lemberg 2010.
Hypertensive Disorder
What do we know about preeclampsia?. Preeclampsia: a two stage disorder Stage 1: Reduced Placental perfusion abnormal implantation Stage 2: Maternal Syndrome.
POSTTERM PREGNANCY: THE IMPACT ON MATERNAL AND FETAL OUTCOME Dr. Hussein. S. Qublan- Al-Hammad Jordanian Board in Obstet &Gynecology European Board in.
Vajiheh Marsoosi, M.D Associate Professor of TUMS Shariati Hospital.
Precepting the Prenatal Patient: A Curriculum for Non OB Family Medicine Physicians.
Hypertension in Pregnancy
UOG Journal Club: March 2016 Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of.
Explaining the Infant Mortality Increase Marian MacDorman, Joyce Martin, T.J.Mathews, Donna Hoyert, and Stephanie Ventura Division of Vital Statistics.
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
Hypertensive Disorders of Pregnancy - Dr Thomas Carins
Clinical features Abnormal vasculogenesis and angiogenesis and releasing of anti-angiogenic factors results in Vasospasm Endothelial dysfunction Etiology.
Endometrial biopsy in subfertile women undergoing intrauterine insemination (IUI) cycles improves pregnancy rates Tumanyan A, Tchzmachyan R, Grigoryan.
PREECLAMPSIA AND SIMPLEX RETINOPATHY ASSOCIATED WITH EARLY SIGNS OF
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Hypertension Disorders in Pregnancy
Objective: To assess the prevalence of anemia in a sample of Jordanian pregnant women and to find out whether packed cell volume (PCV) affected by the.
UOG Journal Club: July 2016 Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study J Min, HA Watson, NL Hezelgrave,
BIOCHEMICAL MARKERS OF PRENATAL DIAGNOSIS
UOG Journal Club: March 2016
Inonu University, Turgut Ozal Medical Centre
Risk Factors Preeclampsia in previous pregnancies
Hypothyroidism during pregnancy
Vital statistics in obstetrics.
Preterm birth < 37 weeks
HYPERTENSIVE DISORDERS OF PREGNANCY
MATERNITY WARD NPH.
Pre-eclampsia Matthew Beaumont.
Predictive value of neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and mean platelet volume for pelvic inflammatory disease Meryem Hocaoğlu.
Intrahepatic cholestasis of pregnancy
Vitamin D insufficiency, preterm delivery and preeclampsia in women with type 1 diabetes – an observational study MARIANNE VESTGAARD1,2,3 , ANNA L. SECHER1,2.
Ümit Görkem1, Cihan ToğruL1, Emine Arslan1, Nafiye Yılmaz2,
James M. Roberts, M.D., Leslie Myatt, Ph.D.,et al.
Ziya Kalem,MD Gurgan Clinic IVF and Women Health Center
Serum soluble fms like tyrosine kinase-1(sflt-1)
The effect of metformin treatment of GDM-patients
Overview of Prenatal Care
Introduction Materials and Methods Results Conclusions
Copyright © 2007 American Medical Association. All rights reserved.
D. Ragland1, M. Jordan1, E. Willcoxon1, S. Ounpraseuth2,
Dr Ferdous Mehrabian. Dr Ferdous Mehrabian Inherited thrombophilias in pregnancy Inherited thrombophilias is a genetic tendency to venous thrombosis.
Fetal growth restriction
Dietary treatment in gestational diabetes: Relation to birth weight
Antepartum Fetal Surveillance
The Utilization of Sequential Compression Devices Among Pregnant Women
(UOG Editor for Trainees)
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
Assisted Reproductive Technology:
Biomarkers in Early Pregnancy
Risk factors for SGA fetus /neonate
Anna David Reader in Obstetrics and Maternal Fetal Medicine
Hypertension in Pregnancy
Hypertensive Disorders In pregnancy
DETERMINANT OF PREECLAMPSIA IN PREGNANT WOMEN AT RSUP PROF. DR
Chantal Nelson BORN Annual Conference April 25, 2017
Presentation transcript:

Investigation of early prognostic factors in the development of early onset preeclampsia Nilay Karaca MD

Introduction To investigate whether complete blood count parameters of early pregnancy or biochemical markers of first trimester trisomy screening were related to prediction of early onset preeclampsia or not. Preeclampsia affects approximately 6-8% of pregnancies (1). It is one of the most fatal events, seen during pregnancy, presents with hypertension (systolic blood pressure ≥ 140 and diastolic blood pressure ≥ 90) and proteinuria (≥300 mg/24 hours or 1+persistent by dipstick) that may arise from early weeks of pregnancy (but generally after 20th gestational weeks) and it has a high morbidity and mortality rate (2). The pathogenesis is not clear and therefore early prediction is mostly not possible (3). Pathologic trophoblastic invasion of maternal vessels causes impairments in placental perfusion and so damages the maternal endothelial cells and destroys their functions by the mediators that flow into maternal circulation. Therefore any of the effective determinants may have great importance in prediction and treatment of the preeclampsia. A balance between the coagulation and anti-coagulation system is essential in formation and continuation of pregnancy. Many biochemical determinants like d- dimer (DD), soluble fms-like tyrosine kinase-1 (sFlt-1) and platelet distribution width (PDW) have been studied (5-7). Elsewhere newer studies focused on neutrophil/ lymphocyte ratio (NLR) and thrombocyte/lymphocyte ratio (TLR) and the researchers showed that the ratio between blood cell subtypes might be promising in diagnose as well determine the prognosis of the diseases which were related with chronic low level of inflammation (8-10). Pregnancy associated plasma protein-A (PAPP-A), is one of the mostly studied first trimester biochemical marker especially in pregnancies complicated with intrauterine growth retardation and preeclampsia (11)

Material- Methods-1 The group 1 ( n=214) was composed from patients between 18-40 year-old with a single pregnancy that diagnosed with preeclampsia at <34th gestational weeks and had delivery at ≥37th weeks of gestation. The group 2 ( n=240) was control. Excluding criteria: Getting pregnant by assisted reproductive technologies Having a body mass index (BMI) >30kg/m2 History of delivery complicated by chromosomal anomalies Current or previous medical problems Multiple pregnancies Patients who had vaginal bleeding at antenatal period History of preterm delivery This was a retrospective case control study of preeclamptic nulliparous women. The study group was composed from patients between 18-40 year-old with a single pregnancy that diagnosed with preeclampsia at <34th gestational weeks and had delivery at ≥37th weeks of gestation. Our control group was composed from 18-40 year old single pregnant women without any complication during pregnancy and gave birth at ≥37th weeks of gestation in the same time period.

Material- Methods-2 Preeclampsia for a pregnancy is defined as having a systolic blood pressure ≥140 and diastolic blood pressure ≥90 as well proteinuria after 20th gestational weeks Blood samples for complete blood count, PAPP-A and free beta-HCG were collected between 11+0 to 13+6 gestational weeks. The two groups were compared with each other due to their demographic features and obstetric and biochemical results. Preeclampsia for a pregnancy is defined as having a systolic blood pressure ≥140 and diastolic blood pressure ≥90 as well proteinuria (300 mg/24 hours or 1+persitant by dipstick) after 20th gestational weeks. Blood pressure was measured at least 2 times with a 6 hours interval, and it was confirmed that patient had at least 30 minutes rest before measurement. Gestational age was calculated due to first day of last menstruation period and/or crown-rump length measurement of first trimester ultrasound. Blood samples for complete blood count, PAPP-A and free beta-HCG were collected between 11+0 to 13+6 gestational weeks. The two groups were compared with each other due to their demographic features and obstetric and biochemical results.

Results The mean gestational weeks at delivery and birth-weight were significantly lower in group 1, comparing to group 2 . NLR and PDW were found significantly higher in preeclampsia group comparing to control group. Lymphocyte count was significantly lower in preeclampsia group. PAPP-A was found lower in the same group .

Demographic and obstetric features of two groups   Group 1 (n=214) Group2(n=240) p-value Maternal age (years) 28.7±3.4 27.5±3.5 0.98 Gravidity 2(1-3) 1(0-2) 0.13 Smoking status 7 (3.2%) 8 (3.4%) 0.90 Gestational weeks at delivery (weeks) 37.6±1.1 40.5±1.5 <0.01 BMI (kg/m2) 22.9±3.2 22.7±3.5 0.09 Birth weight (g) 2845±334 3320±331 In total 454 patients' data was analyzed. The mean age was similar for two groups and it was 28.7±3.4 for group 1 and 27.5±3.5 for group 2 patients. The mean gestational weeks at delivery and birth-weight were significantly lower in group 1, comparing to group 2 (37.6±1.1 vs. 40.5±1.5 weeks, p<0.01 and 2845±334 vs. 3320±331 g, p<0.01). Nevertheless there was no statistically difference for gravidity, smoking status and BMI before the pregnancy between two groups

Comparing two groups for hematological and biochemical markers   Group 1 (n=214) Group 2 (n=240) p-value Leukocyte counts (x103/mm3) 8.7± 1.5 8.5± 1.4 0.57 Leutrophil counts (x103/mm3) 6.8±2.1 6.6±1.4 0.54 Lymphocyte counts (x103/mm3 ) 1.8±0.49 2.3± 0.79 <0.01 Platelet counts (x103/mm3 ) 235± 53 238±41 0.13 NLR 3.96± 1.23 3.22± 1.24 0.05 PLR 119± 51 120± 43 0.87 MPV 10.3±0.85 10.4±1.1 0.24 PCT 0.251±0.04 0.248±0.05 0.77 PDW 12.5±2.1 11.6± 1.87 PAPP-A (MoM) 0.78±0.3 1.19±0.84 free-b-HCG (MoM) 0.99±0.51 1.05±0.47 0.36 NRL and PDW were found significantly higher in preeclampsia group comparing to control group (3.96±1.23 vs. 3.22±1.24, p<0.05 and 12.5±2.1 vs. 11.6±1.87, p<0.01). Against those, lymphocyte count was significantly lower in preeclampsia group (1.8±0.49 vs. 2.3±0.79 x103/mm3, p<0.01). Furthermore, PAPP-A was found lower in the same group (0.78±0.3 vs. 1.19±0.84 MoM, p<0.01). Other CBC parameters as well free b-HCG were found similar in both groups.  

Conclusion We found a strong relation between the high level of NLR and PDW as well low level of lymphocyte count and PAPP-A, with early onset preeclampsia development during the current pregnancy.

Thank you for your attention